Literature DB >> 33741972

Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.

Zhongfang Wang1, Xiaoyun Yang1, Jiaying Zhong1, Yumin Zhou1, Zhiqiang Tang2, Haibo Zhou3, Jun He4, Xinyue Mei1, Yonghong Tang4, Bijia Lin1, Zhenjun Chen5, James McCluskey5, Ji Yang1, Alexandra J Corbett5, Pixin Ran6.   

Abstract

T-cell immunity is important for recovery from COVID-19 and provides heightened immunity for re-infection. However, little is known about the SARS-CoV-2-specific T-cell immunity in virus-exposed individuals. Here we report virus-specific CD4+ and CD8+ T-cell memory in recovered COVID-19 patients and close contacts. We also demonstrate the size and quality of the memory T-cell pool of COVID-19 patients are larger and better than those of close contacts. However, the proliferation capacity, size and quality of T-cell responses in close contacts are readily distinguishable from healthy donors, suggesting close contacts are able to gain T-cell immunity against SARS-CoV-2 despite lacking a detectable infection. Additionally, asymptomatic and symptomatic COVID-19 patients contain similar levels of SARS-CoV-2-specific T-cell memory. Overall, this study demonstrates the versatility and potential of memory T cells from COVID-19 patients and close contacts, which may be important for host protection.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33741972     DOI: 10.1038/s41467-021-22036-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  31 in total

1.  Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19.

Authors:  Athanasios Blanas; Haiko Karsjens; Aafke de Ligt; Elisabeth J M Huijbers; Karlijn van Loon; Stepan S Denisov; Canan Durukan; Diederik J M Engbersen; Jan Groen; Sven Hennig; Tilman M Hackeng; Judy R van Beijnum; Arjan W Griffioen
Journal:  iScience       Date:  2022-07-05

2.  Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease.

Authors:  Giacomo Malipiero; Anna Moratto; Maria Infantino; Pierlanfranco D'Agaro; Elisa Piscianz; Mariangela Manfredi; Valentina Grossi; Enrico Benvenuti; Matteo Bulgaresi; Maurizio Benucci; Danilo Villalta
Journal:  Immunol Res       Date:  2021-08-21       Impact factor: 4.505

3.  [Are SARS-CoV-2 reactive T cells detectable and potentially protective in patients under anti-CD20 treatment with an impaired humoral response?]

Authors:  J Braun; T Westhoff; X Baraliakos; N Babel
Journal:  Z Rheumatol       Date:  2021-09-16       Impact factor: 1.530

Review 4.  Immune profiling of COVID-19: preliminary findings and implications for the pandemic.

Authors:  Holden T Maecker
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

5.  Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.

Authors:  Mariana O Diniz; Nathalie M Schmidt; Oliver E Amin; Aneesh Chandran; Emily Shaw; Leo Swadling; Corinna Pade; Joseph M Gibbons; Nina Le Bert; Anthony T Tan; Anna Jeffery-Smith; Cedric C S Tan; Christine Y L Tham; Stephanie Kucykowicz; Gloryanne Aidoo-Micah; Joshua Rosenheim; Jessica Davies; Marina Johnson; Melanie P Jensen; George Joy; Laura E McCoy; Ana M Valdes; Benjamin M Chain; David Goldblatt; Daniel M Altmann; Rosemary J Boyton; Charlotte Manisty; Thomas A Treibel; James C Moon; Lucy van Dorp; Francois Balloux; Áine McKnight; Mahdad Noursadeghi; Antonio Bertoletti; Mala K Maini
Journal:  Nature       Date:  2021-11-10       Impact factor: 69.504

6.  Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.

Authors:  Kaushik Sen; Sudeshna Datta; Arup Ghosh; Atimukta Jha; Abdul Ahad; Sanchari Chatterjee; Sandhya Suranjika; Soumya Sengupta; Gargee Bhattacharya; Omprakash Shriwas; Kiran Avula; Jayasingh Kshatri; Punit Prasad; Rajeeb Swain; Ajay K Parida; Sunil K Raghav
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

7.  Few SARS-CoV-2 infections detected in Newfoundland and Labrador in the absence of Public Health Laboratory-based confirmation.

Authors:  Danielle P Ings; Keeley M Hatfield; Kathleen E Fifield; Debbie O A Harnum; Kayla A Holder; Rodney S Russell; Michael D Grant
Journal:  PLoS One       Date:  2022-01-28       Impact factor: 3.240

8.  Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.

Authors:  Elisabeth Paul; Garrett W Brown; Andreas Kalk; Valéry Ridde
Journal:  Vaccine       Date:  2021-07-20       Impact factor: 3.641

9.  Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination.

Authors:  Jodi F Hedges; Macy A Thompson; Deann T Snyder; Amanda Robison; Matthew P Taylor; Mark A Jutila
Journal:  Vaccines (Basel)       Date:  2021-06-02

10.  Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19.

Authors:  Maria Laura De Angelis; Federica Francescangeli; Rachele Rossi; Alessandro Giuliani; Ruggero De Maria; Ann Zeuner
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.